Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (precision I) Meeting Abstract
| Authors: | Rodon, J.; Demeure, M.; Deming, D.; Federman, N.; McKean, M.; Lee, E.; Spira, A.; Kwiatkowski, D.; Hussein, M.; Gordon, E.; Crockett, D.; Ganjoo, K.; Schulte, B.; Cranmer, L.; Schmid, A.; Navarro, W.; Itri, L.; Iyer, G. |
| Abstract Title: | Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (precision I) |
| Meeting Title: | IGCS 2022 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Sep 29-Oct 1 |
| Meeting Location: | New York, NY |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2022-12-01 |
| Start Page: | A231 |
| End Page: | A232 |
| Language: | English |
| ACCESSION: | WOS:000899252300483 |
| DOI: | 10.1136/ijgc-2022-igcs.527 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TP018/#1522 -- Source: Wos |
